ATLAS / Macro Radar / Reporting / BCTX

BriaCell Therapeutics Corp. (BCTX) reporting calendar

BriaCell Therapeutics Corp. files periodic reports with the SEC as BCTX on Nasdaq. Atlas tracks 17 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
17 Aug 2026 – 8 Oct 2026
Latest report
10-Q
Period ended
30 Apr 2026
Filed
9 Jun 2026
Reports on record
17

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 92-day cadence, filed a median 43 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open BCTX market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q30 Apr 20269 Jun 202640 days0001493152-26-027928
10-Q31 Jan 202610 Mar 202638 days0001493152-26-009557
10-Q31 Oct 202511 Dec 202541 days0001493152-25-027240
10-K31 Jul 202516 Oct 202577 days0001493152-25-018212
10-Q30 Apr 202516 Jun 202547 days0001641172-25-015265
10-Q31 Jan 202512 Mar 202540 days0001493152-25-010052
10-Q31 Oct 202416 Dec 202446 days0001493152-24-050214
10-K31 Jul 202429 Oct 202490 days0001493152-24-042743
10-Q30 Apr 202414 Jun 202445 days0001493152-24-023867
10-Q31 Jan 202418 Mar 202447 days0001493152-24-010354
10-Q31 Oct 202314 Dec 202344 days0001493152-23-044892
10-K31 Jul 202325 Oct 202386 days0001493152-23-038298
10-Q30 Apr 202314 Jun 202345 days0001493152-23-021287
10-Q31 Jan 202316 Mar 202344 days0001493152-23-007796
10-Q31 Oct 202214 Dec 202244 days0001493152-22-035452
10-K31 Jul 202228 Oct 202289 days0001493152-22-029742
40-F31 Jul 202129 Oct 202190 days0001493152-21-026729

Source: SEC EDGAR company submissions for CIK 0001610820. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.